AstraZeneca PLC (NYSE:AZN)

68.90
Delayed Data
As of Feb 27
 -0.11 / -0.16%
Today’s Change
61.80
Today|||52-Week Range
82.68
-2.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line12.4B7.7B3.3B1.2B
 
 
 
 
 
Depreciation2.0B2.3B2.7B3.3B
 
 
 
 
 
Total Other Cash Flow-5.5B-2.2B1.4B161.3M
 
 
 
 
 
Funds From Operations8.9B7.8B7.3B4.7B
 
 
 
 
 
Funds From/For Other Operating Expenses899.6M707.3M-165.5M-2.5B
 
 
 
 
 
Net Cash Flow - Operating Activities8.0B7.1B7.5B7.2B
 
 
 
 
 
 
InvestingIncrease In Investments-2.8B-46.1M-90.7M-199.2M
 
 
 
 
 
Decrease In Investments0.003.7B167.5M92.6M
 
 
 
 
Capital Expenditures-841.4M-673.3M-739.8M-1.0B
 
 
 
 
 
Fixed Asset Disposal1.9B199.4M110.7M157.4M
 
 
 
 
 
Net Assets From Acquisitions -16.0M-1.2B-1.2B-3.8B
 
 
 
 
 
Other Investing - Uses0.000.000.00-654.3M
 
 
Other Investing - Sources0.000.0034.9M--
 
 
Net Cash Flow Investing-2.2B-2.0B-3.0B-7.1B
 
 
 
 
 
 
FinancingShort Term Borrowings46.1M688.3M-5.0M517.9M
 
 
 
 
 
Long Term Borrowings0.002.0B0.00915.3M
 
 
 
Long Term Debt Reduction0.00-1.8B-26.9M-782.8M
 
 
 
 
Net Proceeds Stock Sale410.2M429.8M480.6M277.9M
 
 
 
 
 
Common Preferred Redeemed-6.0B-2.6B0.00--
 
 
 
Common Dividends-3.7B-3.7B-3.5B-3.5B
 
 
 
 
 
Cash Dividends Paid - Total-3.8B-3.7B-3.5B-3.5B
 
 
 
 
 
Other Sources - Financing3.0M48.1M----
 
 
 
Other Uses - Financing0.000.0035.9M115.5M
 
 
 
Net Cash Flow - Financing-9.3B-4.9B-3.0B-2.7B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-25.1M-4.0M-64.8M-151.4M
 
 
 
 
 
 
Net Change In Cash-3.5B166.3M1.5B-2.7B
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account